Zdrowie i gospodarka · 23/09/2008
FDA Announces Enforcement Action Against Unapproved Topical Papain Products
The FDA is taking enforcement action against unapproved topical drug products containing papain, which are marketed without approved applications to treat necrotic tissue and liquefy slough in acute and chronic lesions, and have been linked to potentially serious adverse events.
Source: Federal Register — Food and Drug AdministrationOpen original release →